Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement.
Material type:
TextPublication details: Geneva : World Health Organization, 2011.Description: 70 pISBN: - 9789241502672
- WF 220 2011US
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ ONLINE-IRIS | WF 220 2011US (Browse shelf(Opens below)) | 1 | Available | 09789241502672 |
Browsing WHO HQ shelves, Shelving location: ONLINE-IRIS Close shelf browser (Hides shelf browser)
| WF 220 2011NO Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: | WF 220 2011SA Same-day diagnosis of tuberculosis: | WF 220 2011TU Tuberculosis prevention, care and control : | WF 220 2011US Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : | WF 250 53WH BCG vaccination : | WF 250 54WH Vaccination against tuberculosis : | WF 250 54WH-1 La vaccination antituberculeuse : |
eng
WHODOC
WHO monograph
WHO guideline.
4
There are no comments on this title.